MoneyWorks4Me

Pharmaids Pharma - Quaterly Results

28 Jan 2022 Evaluate
The Sales for the quarter ended December 2021 of Rs. 7.24 million declined by -78.77% from Rs. 34.10 millions.Net profit stood at Rs. 0.13  millions  compared to Rs. 0.11 millions in the corresponding previous quarter,high by 18.18%.A decline of 0.16 millions was observed in the OP in the quarter ended December 2021 from 0.31 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 7.24 34.10 -78.77 36.36 66.66 -45.45 85.51 0.00 0.00
Other Income 0.00 0.00 0.00 0.00 0.26 0.00 0.26 0.00 0.00
PBIDT 0.16 0.31 -48.39 1.38 1.05 31.43 1.33 -3.36 -139.58
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00
PBDT 0.16 0.31 -48.39 1.38 1.05 31.43 1.33 -3.37 -139.47
Depreciation 0.01 0.11 -90.91 0.09 0.33 -72.73 0.45 0.39 15.38
PBT 0.15 0.20 -25.00 1.29 0.72 79.17 0.88 -3.76 -123.40
TAX 0.02 0.09 -77.78 0.35 0.20 75.00 -0.05 -4.09 -98.78
Deferred Tax 0.02 0.00 0.00 0.35 0.00 0.00 -0.05 -4.09 -98.78
PAT 0.13 0.11 18.18 0.94 0.52 80.77 0.93 0.33 181.82
Equity 102.69 102.69 0.00 103.11 103.11 0.00 102.69 102.69 0.00
PBIDTM(%) 2.21 0.91 143.09 3.80 1.58 140.95 1.56 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..